Zevra Therapeutics, Inc. (ZVRA)
12.06
+0.32
(+2.73%)
USD |
NASDAQ |
Sep 01, 16:00
12.06
0.00 (0.00%)
After-Hours: 18:09
Zevra Therapeutics Free Cash Flow : 32.62M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 32.62M |
| March 31, 2026 | 12.00M |
| December 31, 2025 | -2.433M |
| September 30, 2025 | -24.23M |
| June 30, 2025 | -46.53M |
| March 31, 2025 | -61.82M |
| December 31, 2024 | -69.66M |
| September 30, 2024 | -69.64M |
| June 30, 2024 | -56.30M |
| March 31, 2024 | -45.92M |
| December 31, 2023 | -33.83M |
| September 30, 2023 | -22.10M |
| June 30, 2023 | -23.92M |
| March 31, 2023 | -19.38M |
| December 31, 2022 | -18.81M |
| September 30, 2022 | -15.18M |
| June 30, 2022 | -11.29M |
| March 31, 2022 | 9.422M |
| December 31, 2021 | 7.456M |
| September 30, 2021 | 7.236M |
| June 30, 2021 | 8.919M |
| March 31, 2021 | -5.406M |
| Date | Value |
|---|---|
| December 31, 2020 | -1.972M |
| September 30, 2020 | -3.99M |
| June 30, 2020 | -5.172M |
| March 31, 2020 | -14.71M |
| December 31, 2019 | -23.76M |
| September 30, 2019 | -35.86M |
| June 30, 2019 | -49.58M |
| March 31, 2019 | -51.39M |
| December 31, 2018 | -54.41M |
| September 30, 2018 | -46.15M |
| June 30, 2018 | -40.40M |
| March 31, 2018 | -37.76M |
| December 31, 2017 | -33.28M |
| September 30, 2017 | -36.08M |
| June 30, 2017 | -34.19M |
| March 31, 2017 | -36.10M |
| December 31, 2016 | -30.42M |
| September 30, 2016 | -27.12M |
| June 30, 2016 | -23.47M |
| March 31, 2016 | -20.31M |
| December 31, 2015 | -20.40M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Innoviva, Inc. | 189.44M |
| Collegium Pharmaceutical, Inc. | 328.28M |
| Johnson & Johnson | 22.61B |
| Ligand Pharmaceuticals, Inc. | 119.83M |
| Harrow, Inc. | -13.08M |